RecruitingPhase 3NCT04217512
Pantoprazole in Cisplatin Nephrotoxicity
Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer
Sponsor
Sherief Abd-Elsalam
Enrollment
60 participants
Start Date
May 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Eligibility
Plain Language Summary
Simplified for easier understanding
This study is testing whether pantoprazole (a common over-the-counter stomach acid medication) can protect the kidneys from damage caused by cisplatin, a strong chemotherapy drug frequently used to treat head and neck cancers. Cisplatin is effective but can cause kidney injury as a side effect, and researchers want to see if this simple, widely available medication can reduce that risk.
**You may be eligible if...**
- You have been diagnosed with head and neck cancer
- You are scheduled to receive cisplatin chemotherapy as part of your treatment
**You may NOT be eligible if...**
- Your kidney function is already significantly reduced (GFR below 59 mL/min)
- You have diabetes
- Your liver enzymes are elevated more than 3 times above the normal upper limit
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPantoprazole low dose
Pantoprazole 0.6 mg/kg
DRUGPantoprazole high dose
Pantoprazole 1.6 mg\\kg
OTHERStandard hydration
Standard hydration alone
DRUGCisplatin
Cisplatin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04217512
Related Trials
New Biomarkers in Pancreatic Cancer Using EXPEL Concept
NCT037910731 location
Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy
NCT076332361 location
Leading Healthy Eating and Activity Promotion Program
NCT068685241 location
Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
NCT075922341 location
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT062190831 location